<DOC>
	<DOCNO>NCT01877135</DOCNO>
	<brief_summary>Evaluation 3-years anal carcinoma ( AC ) incidence patient anal AIN3 lesion , factor associate AC . A retrospective cohort study conduct ( 2000-2013 ) follow prospective cohort study ( start 2013 ) new diagnosis anal AIN3 lesion . The main outcome histology proven AC . The 3-years incidence rate AC calculate . Factors associate AC estimate use multivariate Cox regression model .</brief_summary>
	<brief_title>Malignant Progression Anal Intra-epithelial Neoplasia Cohort Patients</brief_title>
	<detailed_description>`` Background : Incidence anal carcinoma ( AC ) considerably increase , data risk AC patient anal AIN3 lesion available , french recommendation screen treatment anal AIN3 lesion . Objective : Evaluation AC incidence patient anal AIN3 lesion , factor associate AC . Population : Patients diagnosis anal AIN3 lesion include follow 3 year . Patients past history AC wo n't include . Study design : Retrospective cohort study conduct 2000 use diagnostic code anal AIN3 lesion histo-pathology department . Then prospective cohort study conduct new diagnosis anal AIN3 lesion . Outcome : The main outcome histology proven AC . AC identification do either use diagnostic code AC histo-pathology department ( retrospective case ) , prospectively . Statistics : The incidence rate AC calculate . Factors associate AC estimate use multivariate Cox regression model . Number patient : 1000 Number center : 35 Length follow-up : 3 year least Length study : 3 year inclusion 3 year follow-up least ''</detailed_description>
	<mesh_term>Anus Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<criteria>To include cohort , patient : anal AIN3 ( include Bowen 's disease ) diagnose histology ( screen population , postoperative discoveryâ€¦ ) Aposteriori patient history anal AIN3 complicate anal cancer . These case identify data base anatomopathology laboratory hospital since January 1st 2000 . At diagnostic new anal AIN3 Units care involve study involved followup patient anal pathology en France , especially anal cancer . Samples analyze laboratory anatomopathology hospital patient diagnose . These point make histological data base reliable allow clearly identifying case anal ain3 retrospectively since 2000 . Taking account number quality unit care involve study way case identify , think recruitment exhaustive France , limit selection bias . Patient 's non opposition study history anal carcinoma without history anal AIN3 lesion impossible followup duration study ( 3 year ) patient age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>anal carcinoma</keyword>
	<keyword>AIN3</keyword>
	<keyword>cohort study</keyword>
</DOC>